In this study, we found that the protein levels of bcl-2 were dramatically decreased after acacetin treatment, while the expression levels of apoptosis-promoter protein Bak were increased in an acacetin dose-dependent manner in NSCLC cells and in A549-xenografted tumors. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.